SOHM, Inc., receives an LOI for an Order worth $1.85 million to supply a range of Generic OTC products in 2013.
SOHM, Inc., receives and accepts LOI to supply a range of Generic OTC products
BUENA PARK, CA—Marketwire – January 17, 2013) – SOHM, Inc. (PINKSHEETS: SHMN) is a globally-known generic pharmaceutical manufacturer, developer and marketer of a wide range of products serving a broad segment of the therapeutics market.
In anticipation of the introduction of SOHM to the huge USA Generic Pharmaceutical market, SOHM has received an LOI for an initial order of $1.85 million to supply a range of Generic OTC products to one of the large California-based pharmaceutical distributors.
Mr. Shailesh Shah, President & C.E.O. of SOHM, Inc., says, “SOHM is very pleased to have received this initial LOI from a California-headquartered distributor that supplies retail networks all across the United States. This represents an annualized commitment to purchase and distribute 9 SOHM products while providing SOHM a lucrative introduction to the huge American market for Generic Pharmaceuticals.
Mr. Shah says this assures SOHM in achieving its target for higher revenue growth and profitability in 2013. It further assures greater utilization of the SOHM manufacturing capability.
About SOHM, Inc.
SOHM, Inc., is a growing generic pharmaceutical manufacturing and marketing company with a global presence and marketing plan that assure continuous growth. SOHM manufacturing and marketing target the rapidly growing healthcare segments such as Nutraceuticals, Cosmeceuticals, and other major therapeutic segments. SOHM is headquartered in North America with manufacturing in India. Although SOHM’s generic pharmaceuticals are exported globally and will be introduced to the USA in early 2013, SOHM continues its focus on distribution to emerging markets in Africa, Latin America, and Southeast Asia.
To know more about SOHM, Inc., visit www.SOHM.com
This press release contains many safe harbour statements such as “project,” “plan,” “can,” etc., in compliance with the guidelines of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Such statements are subject to possible uncertain risks that may vary actual results from those intended in or expressed by the forward-looking statements. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.
For more information, please contact: